Factors associated with serum brain natriuretic peptide levels after the Fontan procedure
- PMID: 21435188
- PMCID: PMC3134550
- DOI: 10.1111/j.1747-0803.2011.00496.x
Factors associated with serum brain natriuretic peptide levels after the Fontan procedure
Abstract
Objective: Although a useful marker of heart failure in adults, the utility of brain natriuretic peptide concentration (BNP) for children after the Fontan procedure is not well studied.
Design: BNP was measured in 510 patients who were 6-18 years old in the Pediatric Heart Network Fontan cross-sectional study at a median of 8.2 years after Fontan. Patients underwent echocardiography, exercise testing, magnetic resonance imaging (MRI) and functional health status questionnaires. Associations of BNP with baseline patient characteristics, medical history and cross-sectional assessment were examined with multivariable linear regression analyses.
Results: The distribution of BNP was highly skewed, median 13.0 pg/mL (interquartile range: 7.1, 25.9), and was normalized with logarithmic transformation (logBNP). Among medical history variables, logBNP was greater in females (P= .02) and older patients (P < .001). Presence of pre-Fontan systolic ventricular dysfunction, greater number of post-Fontan complications, and thrombosis after Fontan were independently associated with higher logBNP (R(2) = 0.16). Age-adjusted logBNP was significantly related to Fontan connection type (lower with extracardiac conduits, higher with atriopulmonary connection; P < .001). Lower physical functioning health status (R(2) = 0.05), lower chronotropic index during exercise (R(2) = 0.17), indices of diastolic dysfunction measured by echocardiography (R(2) = 0.15), and higher total ventricular mass on MRI (R(2) = 0.33) were related to higher logBNP.
Conclusions: Despite a markedly abnormal circulation, BNP was variable but within a normal range in the majority of Fontan patients in this large outpatient cohort. Higher BNP was associated with several markers of suboptimal outcome, although associations were weak. The routine use of BNP as an outpatient surveillance tool in asymptomatic Fontan patients is not warranted.
© 2011 Copyright the Authors. Congenital Heart Disease © 2011 Wiley Periodicals, Inc.
Figures


Similar articles
-
N-terminal pro-brain natriuretic peptide serum levels reflect attrition of the Fontan circulation.Cardiol Young. 2020 Jun;30(6):753-760. doi: 10.1017/S1047951120000657. Cardiol Young. 2020. PMID: 32513314
-
Contemporary outcomes after the Fontan procedure: a Pediatric Heart Network multicenter study.J Am Coll Cardiol. 2008 Jul 8;52(2):85-98. doi: 10.1016/j.jacc.2008.01.074. J Am Coll Cardiol. 2008. PMID: 18598886 Free PMC article.
-
Laboratory measures of exercise capacity and ventricular characteristics and function are weakly associated with functional health status after Fontan procedure.Circulation. 2010 Jan 5;121(1):34-42. doi: 10.1161/CIRCULATIONAHA.109.869396. Epub 2009 Dec 21. Circulation. 2010. PMID: 20026781 Free PMC article.
-
Usefulness of insulin like growth factor 1 as a marker of heart failure in children and young adults after the Fontan palliation procedure.Am J Cardiol. 2015 Mar 15;115(6):816-20. doi: 10.1016/j.amjcard.2014.12.041. Epub 2015 Jan 6. Am J Cardiol. 2015. PMID: 25616534 Free PMC article.
-
Longitudinal Outcomes of Patients With Single Ventricle After the Fontan Procedure.J Am Coll Cardiol. 2017 Jun 6;69(22):2735-2744. doi: 10.1016/j.jacc.2017.03.582. J Am Coll Cardiol. 2017. PMID: 28571639 Free PMC article.
Cited by
-
Fontan-Associated Dyslipidemia.J Am Heart Assoc. 2021 Apr 6;10(7):e019578. doi: 10.1161/JAHA.120.019578. Epub 2021 Mar 31. J Am Heart Assoc. 2021. PMID: 33787283 Free PMC article.
-
Heart failure in adult congenital heart disease.Curr Treat Options Cardiovasc Med. 2014 Sep;16(9):337. doi: 10.1007/s11936-014-0337-y. Curr Treat Options Cardiovasc Med. 2014. PMID: 25131819
-
Diuretic use in the adult Fontan.Int J Cardiol Congenit Heart Dis. 2022 Apr 28;8:100387. doi: 10.1016/j.ijcchd.2022.100387. eCollection 2022 Jun. Int J Cardiol Congenit Heart Dis. 2022. PMID: 39712038 Free PMC article.
-
Diagnosis of Diastolic Dysfunction in Adults With Failing Fontan Circulation.JACC Adv. 2025 Jun;4(6 Pt 1):101758. doi: 10.1016/j.jacadv.2025.101758. Epub 2025 May 14. JACC Adv. 2025. PMID: 40373525 Free PMC article. Review.
-
Cardiac performance and quality of life in patients who have undergone the Fontan procedure with and without prior superior cavopulmonary connection.Cardiol Young. 2013 Jun;23(3):335-43. doi: 10.1017/S1047951112001175. Epub 2012 Jul 24. Cardiol Young. 2013. PMID: 22824161 Free PMC article. Clinical Trial.
References
-
- Maisel AS, Clopton P, Krishnaswamy P, Nowak RM, McCord J, Hollander JE, Duc P, Omland T, Storrow AB, Abraham WT, Wu AH, Steg G, Westheim A, Knudsen CW, Perez A, Kazanegra R, Bhalla V, Herrmann HC, Aumont MC, McCullough PA. Impact of age, race, and sex on the ability of B-type natriuretic peptide to aid in the emergency diagnosis of heart failure: results from the Breathing Not Properly (BNP) multinational study. Am Heart J. 2004;147:1078–1084. - PubMed
-
- Maisel AS, Krishnaswamy P, Nowak RM, McCord J, Hollander JE, Duc P, Omland T, Storrow AB, Abraham WT, Wu AH, Clopton P, Steg PG, Westheim A, Knudsen CW, Perez A, Kazanegra R, Herrmann HC, McCullough PA. Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure. N Engl J Med. 2002;18:161–167. - PubMed
-
- Law YM, Keller BB, Feingold BM, Boyle GJ. Usefulness of plasma B-type natriuretic peptide to identify ventricular dysfunction in pediatric and adult patients with congenital heart disease. Am J Cardiol. 2005;95:474–478. - PubMed
-
- Koch A, Zink S, Singer H. B-type natriuretic peptide in paediatric patients with congenital heart disease. Eur Heart J. 2006;27:861–866. - PubMed
-
- Anderson PA, Sleeper LA, Mahony L, Colan SD, Atz AM, Breitbart RE, Gersony WM, Gallagher D, Geva T, Margossian R, McCrindle BW, Paridon S, Schwartz M, Stylianou M, Williams RV, Clark BJ., III Contemporary outcomes after the Fontan procedure: a Pediatric Heart Network multicenter study. J Am Coll Cardiol. 2008;52:85–98. - PMC - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- HL068288/HL/NHLBI NIH HHS/United States
- HL068285/HL/NHLBI NIH HHS/United States
- U01 HL068269/HL/NHLBI NIH HHS/United States
- U01 HL068279/HL/NHLBI NIH HHS/United States
- U01 HL068290/HL/NHLBI NIH HHS/United States
- U10 HL068270/HL/NHLBI NIH HHS/United States
- U01 HL068281/HL/NHLBI NIH HHS/United States
- U01 HL068270/HL/NHLBI NIH HHS/United States
- HL068290/HL/NHLBI NIH HHS/United States
- HL068279/HL/NHLBI NIH HHS/United States
- U01 HL068288/HL/NHLBI NIH HHS/United States
- HL068281/HL/NHLBI NIH HHS/United States
- U01 HL068292/HL/NHLBI NIH HHS/United States
- HL068269/HL/NHLBI NIH HHS/United States
- HL068270/HL/NHLBI NIH HHS/United States
- U01 HL068285/HL/NHLBI NIH HHS/United States
- HL068292/HL/NHLBI NIH HHS/United States
LinkOut - more resources
Full Text Sources
Medical